Skip to content

Molecular Epidemiology of Clostridium Difficile Infections in Children

Molecular Epidemiologic Survey and Risk Factor Assessment of Clostridium Difficile Infections in Children: A Focus on Recurrent and Community-associated Infections

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01957761
Enrollment
132
Registered
2013-10-08
Start date
2012-10-31
Completion date
2014-06-30
Last updated
2016-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clostridium Difficile Infections

Brief summary

Objectives: 1. Describe the molecular epidemiology of Clostridium Difficile infection in children in the Chicago area. 2. Determine the clinical spectrum and risk factors for Clostridium Difficile infection secondary to particular endemic strains in children. 3. Define the risk factors for recurrent and community-associated Clostridium Difficile infection in children.

Interventions

None listed

Sponsors

Ann & Robert H Lurie Children's Hospital of Chicago
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
1 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* Clostridium Difficile infection

Exclusion criteria

* Age \< 1 year * Age \> 18 years

Design outcomes

Primary

MeasureTime frameDescription
Clostridium Difficile Infections Strain Type Based on Restriction Endonuclease AnalysisOn day 1 of diagnosis of Clostridium difficile infectionStool samples taken from patients with Clostridium Difficile Infections infection at the time of diagnosis will be assessed by restriction endonuclease analysis to determine strain type. In order to study the relationship between strain type and outcome of their infection (e.g, treatment failure, recurrence, complication of illness), patients will be followed throughout their illness and for 8 weeks after developing their infection.

Countries

United States

Participant flow

Participants by arm

ArmCount
Clostridium Difficile Infection
All patients with CDI between 12/2012 and 12/2013 were retrospectively reviewed.
189
Total189

Baseline characteristics

CharacteristicClostridium Difficile Infection
Age, Categorical
<=18 years
176 Participants
Age, Categorical
>=65 years
0 Participants
Age, Categorical
Between 18 and 65 years
13 Participants
Age, Continuous9 years
Number of cases of BI/NAP1/0273 cases
Region of Enrollment
United States
189 participants
Sex: Female, Male
Female
78 Participants
Sex: Female, Male
Male
111 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 189
serious
Total, serious adverse events
0 / 189

Outcome results

Primary

Clostridium Difficile Infections Strain Type Based on Restriction Endonuclease Analysis

Stool samples taken from patients with Clostridium Difficile Infections infection at the time of diagnosis will be assessed by restriction endonuclease analysis to determine strain type. In order to study the relationship between strain type and outcome of their infection (e.g, treatment failure, recurrence, complication of illness), patients will be followed throughout their illness and for 8 weeks after developing their infection.

Time frame: On day 1 of diagnosis of Clostridium difficile infection

ArmMeasureValue (NUMBER)
Clostridium Difficile InfectionClostridium Difficile Infections Strain Type Based on Restriction Endonuclease Analysis3 cases of BI/NAP1/027

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026